ZA975889B - HIV envelope polypeptides and vaccine. - Google Patents

HIV envelope polypeptides and vaccine.

Info

Publication number
ZA975889B
ZA975889B ZA9705889A ZA975889A ZA975889B ZA 975889 B ZA975889 B ZA 975889B ZA 9705889 A ZA9705889 A ZA 9705889A ZA 975889 A ZA975889 A ZA 975889A ZA 975889 B ZA975889 B ZA 975889B
Authority
ZA
South Africa
Prior art keywords
vaccine
hiv envelope
envelope polypeptides
polypeptides
hiv
Prior art date
Application number
ZA9705889A
Other languages
English (en)
Inventor
Phillip W Berman
Original Assignee
Genentech Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Genentech Inc filed Critical Genentech Inc
Publication of ZA975889B publication Critical patent/ZA975889B/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A61P31/18—Antivirals for RNA viruses for HIV
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • A61K2039/525—Virus
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2740/00—Reverse transcribing RNA viruses
    • C12N2740/00011—Details
    • C12N2740/10011—Retroviridae
    • C12N2740/16011—Human Immunodeficiency Virus, HIV
    • C12N2740/16111—Human Immunodeficiency Virus, HIV concerning HIV env
    • C12N2740/16122—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Virology (AREA)
  • Medicinal Chemistry (AREA)
  • Molecular Biology (AREA)
  • General Health & Medical Sciences (AREA)
  • Biophysics (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Biochemistry (AREA)
  • Genetics & Genomics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • AIDS & HIV (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
ZA9705889A 1996-07-08 1997-07-02 HIV envelope polypeptides and vaccine. ZA975889B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US67673796A 1996-07-08 1996-07-08

Publications (1)

Publication Number Publication Date
ZA975889B true ZA975889B (en) 1998-02-23

Family

ID=24715764

Family Applications (1)

Application Number Title Priority Date Filing Date
ZA9705889A ZA975889B (en) 1996-07-08 1997-07-02 HIV envelope polypeptides and vaccine.

Country Status (13)

Country Link
US (1) US6090392A (cg-RX-API-DMAC7.html)
EP (1) EP0942988A1 (cg-RX-API-DMAC7.html)
JP (1) JP2000515368A (cg-RX-API-DMAC7.html)
AP (1) AP1282A (cg-RX-API-DMAC7.html)
AU (1) AU727107B2 (cg-RX-API-DMAC7.html)
CA (1) CA2259965A1 (cg-RX-API-DMAC7.html)
ID (1) ID17767A (cg-RX-API-DMAC7.html)
IL (2) IL127701A0 (cg-RX-API-DMAC7.html)
NZ (1) NZ333500A (cg-RX-API-DMAC7.html)
OA (1) OA10954A (cg-RX-API-DMAC7.html)
TW (1) TWI221846B (cg-RX-API-DMAC7.html)
WO (1) WO1998001564A1 (cg-RX-API-DMAC7.html)
ZA (1) ZA975889B (cg-RX-API-DMAC7.html)

Families Citing this family (35)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6562347B1 (en) 1998-03-12 2003-05-13 The United States Of America As Represented By The Department Of Health And Human Services Chemokine-tumor antigen fusion proteins as cancer vaccines
KR20020075789A (ko) 2000-02-04 2002-10-05 듀크 유니버시티 인체 면역결핍 바이러스 백신
WO2001083535A2 (en) * 2000-05-02 2001-11-08 Simon Fraser University Polypeptides for use as a vaccine and/or treatment for hiv infection
AUPS065002A0 (en) 2002-02-20 2002-03-14 Immunaid Pty Ltd Strategy for retroviral immunotherapy
US20030228320A1 (en) * 2000-08-18 2003-12-11 Ashdown Martin Leonard Retroviral immunotherapy
US7754676B2 (en) 2000-09-15 2010-07-13 The United States Of America As Represented By The Department Of Health And Human Services Defensin-antigen fusion proteins
AU2001291050A1 (en) 2000-09-15 2002-03-26 The Government Of The United States Of America, As Represented By The Secretary Of The Department Of Health And Human Services Viral chemokine-tumur antigen fusion proteins
EP1361886A2 (en) * 2001-02-15 2003-11-19 The Gov. of USA, as represented by the Secretary, Dept. of Health and Human services, National Institutes of Health Methods and compositions for inhibiting hiv-coreceptor interactions
AUPS054702A0 (en) * 2002-02-14 2002-03-07 Immunaid Pty Ltd Cancer therapy
WO2004050856A2 (en) * 2002-12-03 2004-06-17 University Of Massachusetts Polyvalent, primary hiv-1 glycoprotein dna vaccines and vaccination methods
AU2004247146A1 (en) * 2003-06-12 2004-12-23 Vaxgen, Inc. HIV-1 envelope glycoproteins having unusual disulfide structure
US8076060B2 (en) * 2003-08-04 2011-12-13 Emil William Chynn Vaccination and immunotherapy as new therapeutic modalities in the treatment of glaucoma
DK1692516T3 (da) * 2003-10-24 2011-02-28 Immunaid Pty Ltd Terapifremgangsmåde
DK1805510T3 (da) * 2004-09-08 2012-04-30 Immunaid Pty Ltd Terapeutisk strategi til behandling af autoimmune og degenerative sygdomme
PT1794327T (pt) * 2004-09-14 2017-01-24 Argos Therapeutics Inc Amplificação independente de estirpes de patogénios e vacinas para os mesmos
JP2009509970A (ja) * 2005-09-22 2009-03-12 プロサイ インコーポレイテッド 酵母突然変異体において産生されるグリコシル化ポリペプチドおよびその使用方法
WO2009017743A2 (en) 2007-07-30 2009-02-05 Argos Therapeutics, Inc. Improved primers and probes for the amplification and detection of hiv gag, rev and nef polynucleotides
KR101701198B1 (ko) 2008-06-19 2017-02-01 배리에이션 바이오테크놀로지스 아이엔씨. 인플루엔자를 치료하기 위한 조성물 및 방법
PT2435825E (pt) 2009-05-27 2015-11-02 Biotempus Ltd Métodos para o tratamento de doenças
MX2012000372A (es) 2009-07-06 2012-02-28 Variation Biotechnologies Inc Metodos para preparar vesiculas y formulaciones producidas a partir de las mismas.
US9907746B2 (en) 2009-07-06 2018-03-06 Variation Biotechnologies, Inc. Methods for preparing vesicles and formulations produced therefrom
CA2793959C (en) 2010-03-25 2019-06-04 Oregon Health & Science University Cmv glycoproteins and recombinant vectors
CA2840079C (en) 2010-07-06 2018-07-03 Variation Biotechnologies Inc. Compositions and methods for treating influenza
US10736844B2 (en) 2011-01-13 2020-08-11 Variation Biotechnologies Inc. Compositions and methods for treating viral infections
SI2691530T1 (en) 2011-06-10 2018-08-31 Oregon Health & Science University Cmv glycoproteins and recombinant vectors
AU2012216792A1 (en) 2011-09-12 2013-03-28 International Aids Vaccine Initiative Immunoselection of recombinant vesicular stomatitis virus expressing HIV-1 proteins by broadly neutralizing antibodies
EP2586461A1 (en) 2011-10-27 2013-05-01 Christopher L. Parks Viral particles derived from an enveloped virus
WO2013104995A2 (en) 2012-01-12 2013-07-18 Variation Biotechnologies, Inc. Compositions and methods for treating viral infections
CN104244984B (zh) 2012-01-27 2020-03-31 变异生物技术公司 用于治疗剂的方法和组合物
ES2631608T3 (es) 2012-06-27 2017-09-01 International Aids Vaccine Initiative Variante de la glicoproteína Env del VIH-1
WO2014089152A1 (en) 2012-12-04 2014-06-12 University Of Maryland, Baltimore Hiv-1 env-binding antibodies, fusion proteins, and methods of use
US20150065381A1 (en) 2013-09-05 2015-03-05 International Aids Vaccine Initiative Methods of identifying novel hiv-1 immunogens
EP2873423B1 (en) 2013-10-07 2017-05-31 International Aids Vaccine Initiative Soluble hiv-1 envelope glycoprotein trimers
EP3069730A3 (en) 2015-03-20 2017-03-15 International Aids Vaccine Initiative Soluble hiv-1 envelope glycoprotein trimers
US9931394B2 (en) 2015-03-23 2018-04-03 International Aids Vaccine Initiative Soluble HIV-1 envelope glycoprotein trimers

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU600658B2 (en) * 1984-12-24 1990-08-23 Genentech Inc. Molecularly cloned acquired immunodeficiency syndrome polypeptides and their methods of use
ES2102347T3 (es) * 1987-02-20 1997-08-01 Genentech Inc Metodos y composiciones para la utilizacion de polipeptidos env y anticuerpos anti-env de hiv.
IL89118A0 (en) * 1988-02-03 1989-08-15 Microgenesys Inc Vaccine containing polypeptides derived from the envelope gene of human immunodeficiency virus type 1
EP0339504A3 (en) * 1988-04-26 1990-09-12 The Du Pont Merck Pharmaceutical Company Human immunodeficiency virus (hiv) env-coded peptide capable of eliciting hiv-inhibiting antibodies in mammals
US5116740A (en) * 1988-08-16 1992-05-26 Akzo N.V. Method for producing native hiv gp160
AU6523590A (en) * 1989-09-22 1991-04-18 Idec Pharmaceuticals Corporation Novel peptides associated with the cd4 binding region of gp120 and their methods of use
WO1991015512A2 (en) * 1990-04-03 1991-10-17 Genentech, Inc. Hiv envelope polypeptides
JP3494300B2 (ja) * 1990-04-03 2004-02-09 ジェネンテック・インコーポレーテッド Ｈｉｖに対する予防接種のための方法および組成物
CA2164505A1 (en) * 1993-06-07 1994-12-22 Phillip W. Berman Hiv envelope polypeptides

Also Published As

Publication number Publication date
IL127701A0 (en) 1999-10-28
TWI221846B (en) 2004-10-11
CA2259965A1 (en) 1998-01-15
AU3567797A (en) 1998-02-02
AP9901432A0 (en) 1999-03-31
WO1998001564A1 (en) 1998-01-15
NZ333500A (en) 2000-09-29
OA10954A (en) 2001-10-25
IL127701A (en) 2006-08-01
AU727107B2 (en) 2000-11-30
EP0942988A1 (en) 1999-09-22
AP1282A (en) 2004-06-09
JP2000515368A (ja) 2000-11-21
US6090392A (en) 2000-07-18
ID17767A (id) 1998-01-22

Similar Documents

Publication Publication Date Title
ZA975889B (en) HIV envelope polypeptides and vaccine.
EP0708659A4 (en) HIV ENVELOPE POLYPEPTIDE
ZA9811848B (en) Vaccine.
ZA984969B (en) Vaccine.
ZA988789B (en) Vaccine.
CZ20011341A3 (cs) Pomocné přípravky a vakciny
EP0611168A3 (en) Hop extract and its use.
CY2433B1 (en) Interferon conjugates.
ZA991662B (en) Recombinant and adjuvant-containing live vaccines.
ZA972727B (en) A novel composition, its preparation and use.
ZA975533B (en) Cyclosporin-containing pharmaceutical composition.
HUP9802217A3 (en) Recombinant mva virus, and the use thereof
PL331765A1 (en) Trnsplant prosthesis, materials and methods
AU2440997A (en) Calixpyrroles, calixpyridinopyrroles and calixpyridines
ZA976815B (en) Vaccine composition.
ZA975034B (en) Airship.
ZA971663B (en) Porcine reproductive and respiratory syndrome vaccine.
HUP9701586A3 (en) Improved inactivated vaccines
EP0673999A3 (en) Trehalose phosphorylase and its production.
GB9626864D0 (en) Vaccine
ZA9810625B (en) Benzylidenepyrazolones, their preparation and use.
GB2331521B (en) Vaccine preparations
EP0586154A3 (en) Melanin-inhibiting protein, its production and applications.
GB9704977D0 (en) FIV vaccine
ZA9610510B (en) Novel peptides, the preparation and use thereof.